02898

6.3900.00%
FZ

Feng Zhang

Executive Chairman

Mr. Feng Zhang founded Sunho Biologics, Inc. on April 2, 2018. He has been an Executive Chairman of Sunho Biologics, Inc. since July 22, 2023 and appointed as its Director on May 14, 2021. He is responsible for supervising and providing overall management, operation and strategies of Group. Mr. Zhang is the chairman of the board of directors of SunHo (China) BioPharmaceutical and a director of Sunho bio Investments. Mr. Zhang has experience in the pharmaceutical industry. Prior to February 2002, Mr. Zhang worked at pharmaceutical companies, where he was primarily responsible for marketing and promotion of chemical drugs of those companies. Since February 2002, he has been the chairman of the board of directors of Nanjing Yoko where he has been primarily responsible for providing overall management, operation and investment strategies. Mr. Zhang obtained his master’s degree in business administration from the Nanjing University of Science and Technology in Jiangsu in July 2006. Besides, Mr. Zhang has successfully obtained marketing approvals for nearly 20 drugs and manufacturing certificates for over 30 drugs and has been involved in the development of more than 50 clinical and preclinical products, 15 of which are Class 1 or Class 2 new drugs according to the drug classification standards issued by the NMPA. In addition to his leadership in the pharmaceutical industry, Mr. Zhang holds various positions in academic and industry organizations. For instance, he is a member of the sixth editorial board of Progress in Pharmaceutical Sciences, a committee member of the Antitumor Drug Committee of the Chinese Pharmaceutical Association and the vice president of the Jiangsu Provincial Pharmacy Association.

Positions